Opendata, web and dolomites

ENDOGI SIGNED

The first multiple stent delivery system for the treatment of biliary, pancreatic and urologic strictures and stenosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ENDOGI project word cloud

Explore the words cloud of the ENDOGI project. It provides you a very rough idea of what is the project "ENDOGI" about.

market    models    post    plastic    330    safe    stenting    ercp    securing    disrupt    pancreatography    times    mps    day    urinary    placement    insertion    infections    hospitalization    certifications    pancreatic    disorders    diseases    urologic    vascular    endoscope    ducts    patency    tested    validate    device    ischemia    cannulations    retrograde    savings    lumen    prevent    carry    patented    clinical    regulatory    liver    endoscopic    specially    initially    extended    preliminary    feasibility    procedural    duct    hepatic    multiple    disease    urgent    drainage    hospitalizations    optimize    80    settings    penetrate    stents    gastrointestinal    prototype    single    company    reduce    medical    narrowing    innovation    50    boost    completely    biliary    restore    consequence    complications    procedure    endogi    pancreatitis    secure    people    obtain    guidewire    64    launch    bile    20    passage    pig    treatment    phantoms    stenosis    jaundice    cholangio    human    stent    first   

Project "ENDOGI" data sheet

The following table provides information about the project.

Coordinator
ENDO GI MEDICAL LTD 

Organization address
address: 13 WADI EL HAJ
city: NAZARETH
postcode: 16000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website https://www.endo-gi.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ENDO GI MEDICAL LTD IL (NAZARETH) coordinator 50˙000.00

Map

 Project objective

Gastrointestinal diseases affect more than 70 M of people only in US and many of them, e.g. biliary/pancreatic disorders, can have as a consequence biliary, pancreatic or other duct's narrowing (stenosis). In these cases, there is an urgent need to restore lumen patency and drainage in order to prevent complications (e.g. jaundice, infections, liver disease), and they are often treated long-term by stent placement with an ERCP (Endoscopic Retrograde Cholangio-Pancreatography). However, ERCP stenting (specially for multiple stents) still represents many potential complications, associated with extended procedural times and multiple cannulations, which increases the side-effects of the procedure and the ERCP and post-ERCP costs. EndoGI medical has developed the first patented multi-stent delivery system for treatment of biliary, pancreatic and urologic stenosis that allows the safe insertion of multiple plastic stents (MPS) in a controlled, secure and single step. It enables the insertion of 2 or more plastic stents in the bile, hepatic or urinary ducts at 1 endoscope passage and with securing the guidewire throughout the procedure. EndoGI system can reduce up to 50% the cost of hospitalization/day, up to 80% the cost of hospitalization derived from post-ERCP pancreatitis and up to 20% the costs of hospitalizations by ischemia, which represents a 64% of reduction in comparison with common procedure using MPS and 2 delivery systems. We have built-up a first prototype and preliminary tested it with human phantoms and pig models, and now we aim to optimize the device, completely validate it in clinical settings, obtain regulatory certifications and launch it to market. We will initially penetrate the non-vascular stents market and focus in biliary stenting to offer savings of Ëž€330 M/year only in EU. During Phase 1, we will carry out a detailed feasibility study to evaluate the opportunities our innovation has to disrupt the field and boost EndoGI company growth.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENDOGI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENDOGI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More